Trial · NCT01674621
Participant flow25
How many started, completed or left each group, period by period.
1 to 20 of 25
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Abaloparatide Transdermal (50 mcg) | 50 | |
| Overall Study | STARTED | Abaloparatide Transdermal (100 mcg) | 51 | |
| Overall Study | STARTED | Abaloparatide Transdermal (150 mcg) | 48 | |
| Overall Study | STARTED | Abaloparatide Injection (80 mcg) | 51 | |
| Overall Study | STARTED | Abaloparatide Transdermal Placebo (0 mcg) | 50 | |
| Overall Study | Modified Intent-to-Treat Population | Abaloparatide Transdermal (50 mcg) | 47 | |
| Overall Study | Modified Intent-to-Treat Population | Abaloparatide Transdermal (100 mcg) | 46 | |
| Overall Study | Modified Intent-to-Treat Population | Abaloparatide Transdermal (150 mcg) | 43 | |
| Overall Study | Modified Intent-to-Treat Population | Abaloparatide Injection (80 mcg) | 49 | |
| Overall Study | Modified Intent-to-Treat Population | Abaloparatide Transdermal Placebo (0 mcg) | 46 | |
| Overall Study | Safety Population | Abaloparatide Transdermal (50 mcg) | 50 | |
| Overall Study | Safety Population | Abaloparatide Transdermal (100 mcg) | 51 | |
| Overall Study | Safety Population | Abaloparatide Transdermal (150 mcg) | 47 | |
| Overall Study | Safety Population | Abaloparatide Injection (80 mcg) | 51 | |
| Overall Study | Safety Population | Abaloparatide Transdermal Placebo (0 mcg) | 50 | |
| Overall Study | COMPLETED | Abaloparatide Transdermal (50 mcg) | 45 | |
| Overall Study | COMPLETED | Abaloparatide Transdermal (100 mcg) | 43 | |
| Overall Study | COMPLETED | Abaloparatide Transdermal (150 mcg) | 41 | |
| Overall Study | COMPLETED | Abaloparatide Injection (80 mcg) | 45 | |
| Overall Study | COMPLETED | Abaloparatide Transdermal Placebo (0 mcg) | 44 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01674621/flow